Clinical trial
Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
NCT00942877 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 18, 2009
- Completion date
- December 31, 2024
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.